Skip to main content

Navigation group

Main content

Scope

The Environmental Health/Biomarkers/Precision Medicine category invites reports of original research articles and mini reviews that provide novel information on biomarkers with an emphasis on their impact on precision medicine. A primary goal is to identify and examine biomarkers of effect, disposition and susceptibility that prove useful in assessing the safety and efficacy of drugs and biologics as well as the safety of food. Investigations focused on technologies enabling precision medicine in clinical application and biomarker qualification are especially relevant to the drug development process and are welcomed for submission to this section. Submitted manuscripts may include information on the development of innovative biomarkers for application to clinical assessments and to medical product development as well as those relevant to other scientific areas concerning product safety (e.g., foods and devices). The goal is to accelerate development, refinement, and precision application of medical products; assess the safety of food; and provide information on the toxicity of tobacco products. For the reviews, we strongly encourage thought leaders in the biomarker field to discuss emerging and mature biomarkers as they travel the development and qualification process and how they may benefit public health. For original research articles, scientific merit will be emphasized as well as the effective communication of the scientific data including clarity, quality and accuracy of the text, figures and tables, and clarity of methods, experimental design, and statistical analyses.

Associate Editor

William Slikker, Jr., PhD, Retired (formerly US Food and Drug Administration), USA

Review Editors

Ritchie Feuers, PhD, US Food and Drug Administration, USA

Gary Steven Friedman, MD, Pfizer, Inc., USA

Donald J. Johann Jr., MD, University of Arkansas for Medical Sciences, USA

Donald R. Mattison, MD, Risk Sciences International/University of Ottawa, Canada

Donna L. Mendrick, PhD, US Food and Drug Administration, USA

John-Michael Sauer, PhD, Critical Path Institute, USA

Cheng Wang, MD, PhD, US Food and Drug Administration, USA

Paul Brent Watkins, MD, University of North Carolina, USA

Advisory board and editorial team

SEBM’s Publications Committee and EBM’s Editorial Board provides strategic and professional advice to the Editor-in-Chief, Dr Steven Goodman. The journal recognises the following Editorial Board members for their continuous guidance and support of the journal: 

Editor-in-Chief

Steven R. Goodman, PhD, University of Tennessee Health Science Center, Memphis, TN, USA

Assistant to the Editor-in-Chief

Benjamin Zimmer, Society for Experimental Biology and Medicine, Washington D.C., USA

Africa Editor

Gordon Awandare, PhD, University of Ghana, Africa

Asia Editor

Shaw-Jeng Tsai, PhD, National Cheng-Kung University Medical College, Taiwan

Latin America Editor

Nicola Conran, PhD, University of Campinas, Brazil

Europe Editor

Farzin Farzaneh, PhD, King's College London, UK

Australia/Oceana Editor

Dr. Sulev Koks, Murdoch University, Perth, Australia



The full editor list for EBM can be found here.

Journal information

  • Short name

    Exp. biol. med.

  • Abbreviation

    EBM

  • Electronic ISSN

    1535-3699

  • Impact

    3.2 Impact Factor

    5.3 CiteScore

Journal categories

Open access statement

Open access logo

EBM provides online free gold open access to the journal and all of its research publications.

Open Access funder and institutional mandates: EBM is fully compliant with open access mandates, by publishing its articles under the Creative Commons Attribution license  (CC-BY). Funder mandates such as those by the Wellcome Trust (UK), National Institutes of Health (USA) and the Australian Research Council (Australia) are fully compatible with publishing in EBM. Authors retain copyright of their work and can deposit their publication in any repository. The work can be freely shared and adapted provided that appropriate credit is given and any changes specified.

Quality

Each EBM article strives for the highest quality, thanks to genuinely collaborative interactions between authors, editors and reviewers. EBM encourages authors to consult the instructions for authors guidelines prior to submission.

Contact

Frontiers Editorial Office

Avenue du Tribunal Fédéral 34

CH – 1005 Lausanne

Switzerland

Tel +41(0)21 510 17 40

Fax +41 (0)21 510 17 01

For queries regarding thematic issues, fee support, and any other questions, please contact development@ebm-journal.org

For all queries regarding manuscripts in review or potential conflicts of interest, please contact ebm@ebm-journal.org

EBM Editorial Offices

For any additional questions or queries, please contact bzimmer@sebm.org

IT HelpDesk

Tel +41(0)21 510 17 10

Fax +41 (0)21 510 17 01

For technical issues, please visit our HelpDesk, or contact our IT HelpDesk team at support@ebm-journal.org